The relationship of initial transferrin saturation to cardiovascular parameters and outcomes in patients initiating dialysis

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Koo, Hyang Mo ^a   Kim, Chan Ho ^a   Doh, Fa Mee ^a   Lee, Mi Jung ^a   Kim, Eun Jin ^a   Han, Jae Hyun ^a   Han, Ji Suk ^a   Oh, Hyung Jung ^a   Park, Jung Tak ^a   Han, Seung Hyeok ^a   Yoo, Tae Hyun ^a   Kang, Shin Wook ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; HEMOGLOBIN; TRANSFERRIN; TROPONIN;

ADULT; ADVERSE OUTCOME; ANEMIA; ARTICLE; CARDIOVASCULAR INFLAMMATION; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PREDICTOR VARIABLE; PROGNOSIS; TRANSFERRIN BLOOD LEVEL;

ADULT; AGED; ANEMIA; BIOLOGICAL MARKERS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; SURVIVAL RATE; TRANSFERRIN;

EID: 84895530199     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087231     Document Type: Article

References (47)

1. Robinson BE (2006) Epidemiology of chronic kidney disease and anemia. J Am Med Dir Assoc 7: S3-6; quiz S17-21.
2. McClellan W, Aronoff SL, Bolton WK, Hood S, Lorber DL, et al. (2004) The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin 20: 1501-1510. (Pubitemid 39361354)
3. Vlagopoulos PT, Tighiouart H, Weiner DE, Griffith J, Pettitt D, et al. (2005) Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease. J Am Soc Nephrol 16: 3403-3410. (Pubitemid 46179344)
4. Portoles J, Lopez-Gomez JM, Aljama P (2007) A prospective multicentre study of the role of anaemia as a risk factor in haemodialysis patients: the MAR Study. Nephrol Dial Transplant 22: 500-507. (Pubitemid 46189895)
5. Tang YD, Katz SD (2006) Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation 113: 2454-2461.
6. Keane WF, Brenner BM, de Zeeuw D, Grunfeld JP, McGill J, et al. (2003) The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Kidney Int 63: 1499-1507. (Pubitemid 36350016)
7. Kovesdy CP, Trivedi BK, Kalantar-Zadeh K, Anderson JE (2006) Association of anemia with outcomes in men with moderate and severe chronic kidney disease. Kidney Int 69: 560-564. (Pubitemid 43164450)
8. Weiss G, Goodnough LT (2005) Anemia of chronic disease. N Engl J Med 352: 1011-1023.
9. (2006) KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis 47: S11-145.
10. (2012) KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney international supplements 2: 282-335.
11. Wish JB (2006) Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol 1 Suppl 1: S4-8.
12. Wang J, Pantopoulos K (2011) Regulation of cellular iron metabolism. Biochem J 434: 365-381.
13. Dong F, Zhang X, Culver B, Chew HG Jr., Kelley RO, et al. (2005) Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: involvement of nitric oxide synthase and protein tyrosine nitration. Clin Sci (Lond) 109: 277-286. (Pubitemid 41337132)
14. Naito Y, Tsujino T, Matsumoto M, Sakoda T, Ohyanagi M, et al. (2009) Adaptive response of the heart to long-term anemia induced by iron deficiency. Am J Physiol Heart Circ Physiol 296: H585-593.
15. Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, et al. (2010) Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J 31: 1872-1880.
16. van Veldhuisen DJ, Anker SD, Ponikowski P, Macdougall IC (2011) Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches. Nat Rev Cardiol 8: 485-493.
17. Okonko DO, Mandal AK, Missouris CG, Poole-Wilson PA (2011) Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival. J Am Coll Cardiol 58: 1241-1251.
18. Jankowska EA, von Haehling S, Anker SD, Macdougall IC, Ponikowski P (2013) Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. Eur Heart J 34: 816-829.
19. Beutler E, Waalen J (2006) The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood 107: 1747-1750. (Pubitemid 43289347)
20. Michels WM, Grootendorst DC, Verduijn M, Elliott EG, Dekker FW, et al. (2010) Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol 5: 1003-1009.
21. Steiber AL, Kalantar-Zadeh K, Secker D, McCarthy M, Sehgal A, et al. (2004) Subjective Global Assessment in chronic kidney disease: a review. J Ren Nutr 14: 191-200. (Pubitemid 39360974)
22. Park HJ, Kim S, Yong JS, Han SS, Yang DH, et al. (2007) Reliability and validity of the Korean version of Kidney Disease Quality of Life instrument (KDQOL-SF). Tohoku J Exp Med 211: 321-329. (Pubitemid 46585545)
23. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, et al. (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57: 450-458. (Pubitemid 16119719)
24. Liao Y, Cooper RS, Durazo-Arvizu R, Mensah GA, Ghali JK (1997) Prediction of mortality risk by different methods of indexation for left ventricular mass. J Am Coll Cardiol 29: 641-647. (Pubitemid 27116109)
25. Li S, Collins AJ (2004) Association of hematocrit value with cardiovascular morbidity and mortality in incident hemodialysis patients. Kidney Int 65: 626-633. (Pubitemid 38130658)
26. Drueke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, et al. (2006) Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355: 2071-2084. (Pubitemid 44749316)
27. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, et al. (2006) Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355: 2085-2098. (Pubitemid 44749317)
28. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, et al. (2009) A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 361: 2019-2032.
29. Anand IS (2008) Anemia and chronic heart failure implications and treatment options. J Am Coll Cardiol 52: 501-511.
30. Nanas JN, Matsouka C, Karageorgopoulos D, Leonti A, Tsolakis E, et al. (2006) Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol 48: 2485-2489. (Pubitemid 44881220)
31. Toblli JE, Lombrana A, Duarte P, Di Gennaro F (2007) Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol 50: 1657-1665. (Pubitemid 47562670)
32. Silverberg DS, Wexler D, Iaina A, Schwartz D (2008) The role of correction of anaemia in patients with congestive heart failure: a short review. Eur J Heart Fail 10: 819-823.
33. Franchini M, Targher G, Montagnana M, Lippi G (2008) Iron and thrombosis. Ann Hematol 87: 167-173.
34. Dallman PR (1986) Biochemical basis for the manifestations of iron deficiency. Annu Rev Nutr 6: 13-40.
35. Maeder MT, Khammy O, dos Remedios C, Kaye DM (2011) Myocardial and systemic iron depletion in heart failure implications for anemia accompanying heart failure. J Am Coll Cardiol 58: 474-480.
36. Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, et al. (2009) Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 361: 2436-2448.
37. Comin-Colet J, Lainscak M, Dickstein K, Filippatos GS, Johnson P, et al. (2013) The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study. Eur Heart J 34: 30-38.
38. Murphy CJ, Oudit GY (2010) Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment. J Card Fail 16: 888-900.
39. Kremastinos DT, Farmakis D (2011) Iron overload cardiomyopathy in clinical practice. Circulation 124: 2253-2263.
40. Mainous AG 3rd, Gill JM, Carek PJ (2004) Elevated serum transferrin saturation and mortality. Ann Fam Med 2: 133-138. (Pubitemid 39329081)
41. Ellervik C, Tybjaerg-Hansen A, Nordestgaard BG (2011) Total mortality by transferrin saturation levels: two general population studies and a metaanalysis. Clin Chem 57: 459-466.
42. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, et al. (2004) Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int 65: 1492-1498. (Pubitemid 38406992)
43. London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, et al. (2001) Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 12: 2759-2767. (Pubitemid 33115424)
44. Cachofeiro V, Goicochea M, de Vinuesa SG, Oubina P, Lahera V, et al. (2008) Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int Suppl: S4-9.
45. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, et al. (2004) Creactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350: 1387-1397. (Pubitemid 38419992)
46. Han SS, Ahn JM, Chin HJ, Chae DW, Oh KH, et al. (2010) Impact of Creactive protein and pulse pressure evaluated at the start of peritoneal dialysis on cardiovascular events in the course of treatment with peritoneal dialysis. Perit Dial Int 30: 300-310.
47. Robinson BM, Port FK (2009) International hemodialysis patient outcomes comparisons revisited: the role of practice patterns and other factors. Clin J Am Soc Nephrol 4 Suppl 1: S12-17.